Department Of Gastroenterology 3
101. The case for simplifying and using absolute targets for viral hepatitis elimination goals
102. The case for simplifying and using absolute targets for viral hepatitis elimination goals
103. The case for simplifying and using absolute targets for viral hepatitis elimination goals
104. The case for simplifying and using absolute targets for viral hepatitis elimination goals
105. Probiotics and Fecal Transplant: An Intervention in Delaying Chronic Kidney Disease Progression?
106. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
107. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
108. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
109. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
110. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
111. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
112. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
113. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
114. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
115. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
116. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
117. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
118. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
119. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
120. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
121. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
122. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
123. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
124. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
125. Apoptotic cell death in disease—Current understanding of the NCCD 2023
126. Characteristics of Hepatitis B and C Infections in Hemodialysis Patients in Almaty, Kazakhstans Largest City
127. Characteristics of Hepatitis B and C Infections in Hemodialysis Patients in Almaty, Kazakhstans Largest City
128. Exploring the complex interplay of Blastocystis, morbid obesity, and bariatric surgery on gut microbial dynamics
129. Exploring the complex interplay of Blastocystis, morbid obesity, and bariatric surgery on gut microbial dynamics
130. Global burden of metabolic diseases, 1990–2021
131. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
132. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
133. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
134. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
1 2 3 3